ArticleBioscience reports2025
Anti-tumor and immunomodulatory activity of Ganoderma parvulum-derived polysaccharides.
Article in Bioscience reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polysaccharides have gained considerable attention recently because of their anti-tumor and immunoregulatory properties. Its activity depends on the type of fungus that produces it, the extraction method, and the molecular weight. MATERIALS AND
methodsThis study evaluated the anti-tumor and immunoregulatory properties of Ganoderma parvulum (GP)-derived polysaccharides.
resultsGP crude polysaccharides inhibited mice's lymphoma without cytotoxicity. In vitro studies showed that exopolysaccharides (GEPS) and intrapolysaccharides (GIPS) of G. parvulum inhibited the proliferation of tumor cells, but no cell death was observed. Significantly, GEPS and GIPS increased the production of nitric oxide, TNF-α, MCP-1, and an increase in IL-1β, IL-18, and Caspase-1, while NLRP3 was down-regulated. Also, it decreases the production of IL-10 and IL-6.
conclusionThese observations suggest that GP-derived polysaccharides may exert anti-tumor activity primarily by activating the host's immune system via macrophage stimulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.